Market Cap 325.91M
Revenue (ttm) 0.00
Net Income (ttm) -3.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 51,100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 26.76M
Stochastic %K 22%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting ther...

Industry: Biotechnology
Sector: Healthcare
Phone: (604) 315-4722
Address:
50 West Liberty Street, Suite 880, Reno, United States
Mikiminingmouse
Mikiminingmouse Jun. 23 at 3:02 PM
$CNXU good stuff
0 · Reply
mate8
mate8 Jun. 23 at 2:32 PM
0 · Reply
stocks_2watch
stocks_2watch Jun. 23 at 2:26 PM
$CNXU, has a Promising Webinar upcoming with their President & CEO Miles Harrison will discuss the high-growth markets Conexeu is targeting, including its recent expansion into regenerative aesthetics, sign Up: https://globalonemedia.zoom.us/webinar/register/WN_iPU1kk8VSHeyXl2xOwlKUA#/registration
0 · Reply
topstockalerts
topstockalerts Jun. 16 at 9:17 PM
$CNXU this one is sneaking up on people
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 16 at 12:51 PM
$CNXU future zero
0 · Reply
mate8
mate8 Jun. 15 at 10:31 AM
0 · Reply
Mikiminingmouse
Mikiminingmouse Jun. 15 at 10:18 AM
$CNXU Nice to see some progress here. Manufacturing has been transferred to their CDMO partner and they're now producing material for final regulatory testing, which feels like another step toward commercialization.
0 · Reply
MadMaverick
MadMaverick Jun. 9 at 2:47 PM
$CNXU UPDATE Since our $11 entry, $CNXU has been volatile—hitting $18.79 before consolidating around $14.40. The thesis remains strong: Conexeu Sciences is hitting key manufacturing milestones for their CXU™ wound care platform ahead of that 2027 510(k) filing. We’re currently in a period of price discovery. Whether you’re long for the 2027 catalysts or playing the intraday moves, keep your risk tight and watch the volume as we stabilize above those sub-$12 levels. Communicated Disclaimer: stockresearchtoday.com/cnxu/ $CCTG $CHAI $AZI $PAVS
0 · Reply
brennan_lucas999
brennan_lucas999 Jun. 9 at 8:53 AM
0 · Reply
kate8delgado8
kate8delgado8 Jun. 9 at 8:39 AM
0 · Reply
Mikiminingmouse
Mikiminingmouse Jun. 23 at 3:02 PM
$CNXU good stuff
0 · Reply
mate8
mate8 Jun. 23 at 2:32 PM
0 · Reply
stocks_2watch
stocks_2watch Jun. 23 at 2:26 PM
$CNXU, has a Promising Webinar upcoming with their President & CEO Miles Harrison will discuss the high-growth markets Conexeu is targeting, including its recent expansion into regenerative aesthetics, sign Up: https://globalonemedia.zoom.us/webinar/register/WN_iPU1kk8VSHeyXl2xOwlKUA#/registration
0 · Reply
topstockalerts
topstockalerts Jun. 16 at 9:17 PM
$CNXU this one is sneaking up on people
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 16 at 12:51 PM
$CNXU future zero
0 · Reply
mate8
mate8 Jun. 15 at 10:31 AM
0 · Reply
Mikiminingmouse
Mikiminingmouse Jun. 15 at 10:18 AM
$CNXU Nice to see some progress here. Manufacturing has been transferred to their CDMO partner and they're now producing material for final regulatory testing, which feels like another step toward commercialization.
0 · Reply
MadMaverick
MadMaverick Jun. 9 at 2:47 PM
$CNXU UPDATE Since our $11 entry, $CNXU has been volatile—hitting $18.79 before consolidating around $14.40. The thesis remains strong: Conexeu Sciences is hitting key manufacturing milestones for their CXU™ wound care platform ahead of that 2027 510(k) filing. We’re currently in a period of price discovery. Whether you’re long for the 2027 catalysts or playing the intraday moves, keep your risk tight and watch the volume as we stabilize above those sub-$12 levels. Communicated Disclaimer: stockresearchtoday.com/cnxu/ $CCTG $CHAI $AZI $PAVS
0 · Reply
brennan_lucas999
brennan_lucas999 Jun. 9 at 8:53 AM
0 · Reply
kate8delgado8
kate8delgado8 Jun. 9 at 8:39 AM
0 · Reply
mate8
mate8 Jun. 8 at 7:43 PM
$CNXU ff their collagen based tech gains traction there could be some real upside here. Definitely one to keep an eye on
0 · Reply
stocks_2watch
stocks_2watch Jun. 8 at 7:37 PM
$CNXU, Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™️ Wound Care Program, link to PR: https://ir.conexeu.com/news-events/press-releases/detail/99/conexeu-sciences-reports-manufacturing-scale-up-and-regulatory-progress-for-lead-cxu-wound-care-program
0 · Reply
stocks_2watch
stocks_2watch Jun. 8 at 7:19 PM
$CNXU, Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026, take a Look: https://ir.conexeu.com/news-events/press-releases/detail/98/conexeu-sciences-to-ring-nasdaq-bell-on-june-10-2026
0 · Reply
prismmarketview
prismmarketview Jun. 8 at 6:47 PM
$CNXU Conexeu Sciences on the move as Conexeu Sciences advances its collagen‑based CXU scaffold toward a planned 510(k) filing and scales manufacturing with its CDMO partner. Early‑stage, but a clear regulatory roadmap is forming. #CNXU #MedicalDevices #WoundHealing #Biotech https://prismmarketview.com/conexeu-sciences-steps-up-as-cxu-wound-care-device-nears-the-fda-runway/
0 · Reply
Ravisloses
Ravisloses Jun. 8 at 2:39 PM
$CNXU gpus flying
0 · Reply
Ravisloses
Ravisloses Jun. 8 at 2:29 PM
$CNXU gpus supposed to gain overnight
0 · Reply
Flinty2009
Flinty2009 Jun. 8 at 1:37 PM
0 · Reply
MarketBeat
MarketBeat Jun. 4 at 2:51 PM
https://marketbeat.com/a/8690839/ $FJET $BUD $CNXU $NUCL $FJET Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
0 · Reply
masonRhiiine
masonRhiiine Jun. 4 at 11:26 AM
0 · Reply
MadMaverick
MadMaverick Jun. 3 at 7:05 PM
$CNXU UPDATE Since our initial coverage at $11, $CNXU has surged to $18+.💰 The regenerative medicine thesis remains strong, but as with any momentum move, protecting your position is key. Consider tightening stop losses or taking partial profits to lock in these gains while keeping exposure to the 2027 milestone potential. Trade smart and manage your risk. Communicated Disclaimer: https://stockresearchtoday.com/cnxu/ $XOS $SBEV $FOFO $STAK
0 · Reply
stocks_2watch
stocks_2watch Jun. 3 at 5:43 PM
Beyond Implants: How Conexeu’s ( $CNXU ) B.R.E.A.S.T.™️ Could Advance Tissue Regeneration, Take a Look: https://www.youtube.com/watch?v=N8thuQMx6Z8
0 · Reply
wizeinvesting
wizeinvesting Jun. 3 at 8:30 AM
$ASTS $UCLE $FJET $CNXU The biggest misconception in investing is that IPOs are where wealth is created, when in reality they are often where early wealth creation is simply revealed. By the time companies like SpaceX dominate public conversation, much of the asymmetric upside has already been absorbed in private markets long before retail investors ever see a ticker. Understanding how capital moves through private funding stages, narrative cycles, and eventual public listings is essential for recognizing where real opportunity is formed versus where it is simply redistributed. In the full breakdown, we explore how private markets quietly shape the biggest winners in space, AI, and biotech—and why the most important investing edge today is not access to IPOs, but understanding what happens years before they ever arrive. https://www.wizeinvesting.com/p/30k-turned-into-148k-in-5-years
0 · Reply